Pathogenesis of psoriatic arthritis;Pathogénie du rhumatisme psoriasique

Revue du Rhumatisme (Edition Francaise)

Volumn 69, Issue 6, 2002, Pages 608-614

  Lioté, Frédéric ^a  

^a CENTRE VIGGO PETERSEN   (France)

Author keywords

HLA; Lymphocyte; Psoriasis; Psoriatic arthritis; Streptococcus

Indexed keywords

EID: 0242716310     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(02)00349-6     Document Type: Short Survey

References (38)

1. Stern RS. Psoriasis. Lancet 1997 ; 350 : 349-53.
2. Asadullah K, Volk HD, Sterry W. Novel immunotherapies for psoriasis. Trends Immunology 2002 ; 23 : 47-53.
3. Höhler T, Märker-Hermann E. Psoriatic arthritis : clinical aspects, genetics, and the role of T cells. Curr Opin Rheumatol 2001 ; 13 : 273-9.
4. Prinz J. Psoriasis vulgaris-a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol 2001 ; 26 : 326-32.
5. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995 ; 1 : 442-7.
6. Espinoza LR, Vasey FB, Oh JH, Wilkinson R, Osterland CK. Association between HLA-BW38 and peripheral psoriatic arthritis. Arthritis Rheum 1978 ; 21 : 72-5.
7. Kammer GM, Soter NA, Gibson DJ, Schur PH. Psoriatic arthritis : a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 1979 ; 9 : 75-97.
8. Arnett FC, Bias WB. HLA-Bw38 and 39 in psoriatic arthritis : relationships and implications for peripheral and axial involvement. Arthritis Rheum 1980 ; 23 : 649-54.
9. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis : multivariate relative risk model. Arthritis Rheum 1995 ; 38 : 845-50.
10. Gladman DD, Farewell VT, Kopciuk KA, Cook RJ. HLA markers and progression in psoriatic arthritis. J Rheumatol 1998 ; 25 : 730-3.
11. Punzi L, Pianon M, Rizzi E. Prévalence du rhumatisme psoriasique post-traumatique [lettre]. Presse Méd 1997 ; 26 : 420.
12. Fearon U, Veale DJ. Pathogenesis of psoriatic arthritis. Clin Exp Dermatol 2001 ; 26 : 333-7.
13. Sandorfi N, Freundlich B. Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset : 4 cases and review of litterature. J. Rheumatol 1997 ; 24 : 187-92.
14. Sibilia J, Cribier B, Javier RM, Kuntz JL. Recurrent psoriatic onychoperisotosis induced by hydroxychloroquine. Rev Rhum [Engl Ed] 1995 ; 62 : 795-7.
15. Wang Q, Vassey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, et al. V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 1999 ; 42 : 2055-9.
16. Thomssen H, Hoffmann B, Schank M, Elewaut D, Meyer zun Buschenfelde KH, Marker-Hermann E. There is no disease-specific role for streptococci-responsive synovial T lymphocytes in the pathogenesis of psoriatic arthritis. Med Microbiol Immunol 2000 ; 188 : 203-7.
17. Gladman DD. Psoriatic arthritis. Review of current concepts. Isr J Med Sci 1991 ; 27 : 228-33.
18. Peterson KS, Winchester R. Psoriatic arthritis. In : Fitzpatrick TB, Eisen AK, Wolff T KIM, Freedberg FF, Austen, Eds. Dermatology in general medicine. New York : McGraw-Hill ; 1999.
19. Partsch G, Wagner E, Leeb BF, Broll H, Dunky A, Smolen JS. T cell derived cytokines in psoriatic arthritis synovial fluids. Ann Rheum Dis 1998 ; 57 : 691-3.
20. Steinsson K, Jonsdottir I, Valdimarsson H. Cyclosporin A in psoriatic arthritis : an open study. Ann Rheum Dis 1990 ; 49 : 603.
21. + T lymphocytes in psoriatic arthritis. J Rheumatol 1999 ; 26 : 1117-24.
22. Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 1987 ; 123 : 1622-32.
23. Winchester R, Bernstein DM, Fischer HD, Enlow R, Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987 ; 106 : 19-26.
24. Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B, et al. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions that appear antigen driven. J Immunol 2001 ; 166 : 2878-86.
25. Tassiulas I, Duncan SR, Centola M, Theofilopoulos AN, Boumpas DT. Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol 1999 ; 60 : 479-91.
26. Mitchison N. Linked A. Help in the cytotoxic T-cell response revealed by adoptive transfer. Transplant Proc 1983 ; 15 : 2121-4.
27. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998 ; 393 : 474-8.
28. Stuhler G, Schlossman SF. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc Nad Acad Sci USA 1997 ; 94 : 622-7.
29. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998 ; 25 : 1544-52.
30. Ritchlin C, Dwyer E, Bucala R, Winchester R. Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol 1994 ; 40 : 292-8.
31. Ritchlin C, Haas-Smith SA. Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells. J Rheumatol 2001 ; 28 : 698-705.
32. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy : a new therapeutic approach. J Clin Invest 1998 ; 101 : 783-94.
33. McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, et al. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol 2001 ; 167 : 4075-82.
34. Freemont AJ, Denton J. Disease distribution of synovial fluid mast cells and cytophagocytic mononuclear cells in inflammatory arthritis. Ann Rheum Dis 1985 ; 44 : 312-5.
35. Fraser A, Fearon U, Reece R, Emery P, Veale DJ. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 2001 ; 44 : 2024-8.
36. Fearon U, Reece R, Smith J, Emery P, Veale DJ. Synovial cytokine and growth factor regulation of MMPs/TIMPs : implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci 1999 ; 878 : 619-21.
37. Fournié A, Ayrolles C, Sellami S, Guyard C, Fournié B. Histoire naturelle du rhumatisme psoriasique. Rev Rhum Mal Ostéoartic 1980 ; 47 : 309-16.
38. Ritchlin CT, Daikh BE. Recent advances in the treatment of the seronegative spondyloarthropathies. Curr Rheumatol Rep 2001 ; 3 : 399-403.